LMVTX
Price
$95.03
Change
+$0.36 (+0.38%)
Updated
Jul 3 closing price
Net Assets
3.89B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LMVTX vs VIVAX

Header iconLMVTX vs VIVAX Comparison
Open Charts LMVTX vs VIVAXBanner chart's image
ClearBridge Value C
Price$95.03
Change+$0.36 (+0.38%)
VolumeN/A
Net Assets3.89B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LMVTX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMVTX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVTX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. LMVTX (3.89B). VIVAX pays higher dividends than LMVTX: VIVAX (2.06) vs LMVTX (0.04). LMVTX was incepted earlier than VIVAX: LMVTX (43 years) vs VIVAX (33 years). LMVTX (1.76) is less costly to investors than VIVAX (0.17). LMVTX is a more actively managed with annual turnover of: 54.00 vs. VIVAX (9.00). LMVTX has a lower initial minimum investment than VIVAX: LMVTX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. LMVTX (-1.01). VIVAX return over 5 years is better than : 80.14 vs. LMVTX (30.73).
LMVTXVIVAXLMVTX / VIVAX
Total Expense Ratio1.740.171,024%
Annual Report Gross Expense Ratio1.760.171,035%
Fund Existence43 years33 years-
Gain YTD3.8696.20962%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets3.89B189B2%
Annual Yield % from dividends0.042.062%
Returns for 1 year-1.0112.04-8%
Returns for 3 years15.2735.1643%
Returns for 5 years30.7380.1438%
Returns for 10 years45.90115.7440%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings